Cargando…
Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas
AIMS: Nearly 60% of the world's population lives in Asia but little is known about the characteristics and outcomes of Asian patients with heart failure with reduced ejection fraction (HFrEF) compared to other areas of the world. METHODS AND RESULTS: We pooled two, large, global trials, with si...
Autores principales: | Dewan, Pooja, Jhund, Pardeep S., Shen, Li, Petrie, Mark C., Abraham, William T., Atif Ali, M., Chen, Chen‐Huan, Desai, Akshay S., Dickstein, Kenneth, Huang, Jun, Kiatchoosakun, Songsak, Kim, Kee‐Sik, Køber, Lars, Lai, Wen‐Ter, Liao, Yuhua, Mogensen, Ulrik M., Oh, Byung‐Hee, Packer, Milton, Rouleau, Jean L., Shi, Victor, Sibulo, Antonio S., Solomon, Scott D., Sritara, Piyamitr, Swedberg, Karl, Tsutsui, Hiroyuki, Zile, Michael R., McMurray, John J.V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607486/ https://www.ncbi.nlm.nih.gov/pubmed/30536678 http://dx.doi.org/10.1002/ejhf.1347 |
Ejemplares similares
-
The prognostic value of troponin T and N‐terminal pro B‐type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes
por: Rørth, Rasmus, et al.
Publicado: (2018) -
Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM‐HF)
por: Mogensen, Ulrik M., et al.
Publicado: (2018) -
Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM‐HF
por: Yeoh, Su E., et al.
Publicado: (2020) -
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox
por: Butt, Jawad H, et al.
Publicado: (2023) -
Serum potassium in the PARADIGM‐HF trial
por: Ferreira, João Pedro, et al.
Publicado: (2020)